血清胆红素与2型糖尿病合并非酒精性脂肪肝病相关性研究进展被引量：1

Relationship between serum bilirubin and type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease

导出

摘要非酒精性脂肪肝病(NAFLD)是一种与胰岛素抵抗(IR)和遗传易感密切相关的代谢应激性肝损伤,其由轻到重包括非酒精性肝脂肪变、非酒精性脂肪性肝炎、肝硬化和肝细胞癌四个阶段,是我国常见的慢性肝病之一。流行病学研究表明,普通成人NAFLD患病率介于6.3%~45%(中位数25.2%,95%CI:22.1%~28.7%)[1]。

作者赵盼盼李强 ZHAO Pan-pan;LI Qiang(Depaartment of Endocrinology and Metabolism,Second Affiliated Hospital of Harbin Medical University,Herbin 150086,China)

机构地区哈尔滨医科大学附属第二医院内分泌代谢病科

出处《中国实用内科杂志》 CAS CSCD 北大核心 2019年第6期568-571,共4页 Chinese Journal of Practical Internal Medicine

基金黑龙江省科技攻关课题(GA07C303107)

关键词胆红素 2型糖尿病非酒精性脂肪肝病糖脂代谢胰岛素信号传导 bilirubin type 2 diabetes nonalcoholic fatty liver glycolipid metabolism the conduction of insulin signal

分类号 R587.1 [医药卫生—内分泌] R575.5 [医药卫生—消化系统]

引文网络
相关文献

参考文献2

1无,范建高,魏来,庄辉.非酒精性脂肪性肝病防治指南(2018年更新版)[J].实用肝脏病杂志,2018,21(2):177-186. 被引量：168
2齐潇雁,肖新华.非酒精性脂肪肝与2型糖尿病研究进展[J].中国现代医药杂志,2015,17(12):89-92. 被引量：8

二级参考文献43

1Smith BW,Adams LA. Nonalcoholic fatty liver disease and dia- betes mellitus: pathogenesis and treatment[J]. Nat Rev Endocrinol, 2011,7(8) :456-465.
2Kantartzis K,Machann J,Schick F,et al. The impact of liver fat vs visceral fat in determining categories of prediabetes[J]. Diabetolo- gia,2010,53(5) :882-889.
3Targher G, Byme CD. Clinical Review : Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications[J]. J Clin Endocrinol Metab, 2013,98 (2) : 483-495.
4Samuel VT, Liu ZX, Qu X, et al. Mechanism of hepatic insulin re- sistance in non-alcoholic fatty liver disease [J]. J Biol Chem, 2004,279(31 ) :32345-32353.
5Gao Z,Zhang J,Kheterpal I,et al. Sirtuin 1 (SIRT1) protein degra- dation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity[J]. J Biol Chem, 2011,286 (25) : 22227-22234.
6Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney dis- ease,and fatty liver disease : the roles of fetuin-A ,adiponectin, and AMPK[J]. J Am Soc Nephrol,2010,21 (3):406-412.
7Bugianesi E ,Gastaldelli A,Vanni E ,et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms[J]. Diabetologia,2005,48(4) :634-642.
8Odegaard JI, Chawla A. Alternative macrophage activation and metabolism[J]. Annu Rev Pathol, 2011,6 : 275-297.
9Hotamisligil GS. Inflammation and metabolic disorders[J]. Nature, 2006,444(7121 ) :860-867.
10Hotamisligil GS,Johnson RS,Distel RJ,et al. Uncoupling of obe- sity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein [J]. Science,1996,274 (5291) : 1377-1379.